Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years

BACKGROUND: Hunter Syndrome is an X-linked lysosomal storage disorder due to the deficit of iduronate 2-sulfatase, an enzyme catalysing the degradation of the glycosaminoglycans (GAG) dermatan- and heparan-sulfate. Treatment of the disease is mainly performed by Enzyme Replacement Therapy (ERT) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomanin, Rosella, Zanetti, Alessandra, D’Avanzo, Francesca, Rampazzo, Angelica, Gasparotto, Nicoletta, Parini, Rossella, Pascarella, Antonia, Concolino, Daniela, Procopio, Elena, Fiumara, Agata, Borgo, Andrea, Frigo, Anna Chiara, Scarpa, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180060/
https://www.ncbi.nlm.nih.gov/pubmed/25231261
http://dx.doi.org/10.1186/s13023-014-0129-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180060/
https://www.ncbi.nlm.nih.gov/pubmed/25231261
http://dx.doi.org/10.1186/s13023-014-0129-1

Ejemplares similares